Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.

May 2025 saw several significant developments in the field of cardiology, including new regulatory approvals, long-term clinical trial data and important findings from late-breaking studies. This roundup highlights the latest updates across structural, interventional and heart failure therapies, with implications for ...

The ACT-EARLY clinical trial has dosed its first participant in an effort to prevent variant transthyretin amyloidosis (ATTRv) in genetically at-risk individuals. By evaluating the selective TTR stabilizer, acoramidis, in asymptomatic carriers, the study aims to delay or halt disease onset. With approximately 600 participants, ACT-EARLY marks a pivotal step toward shifting ATTRv care from reactive treatment to proactive prevention.

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

Findings from a Phase IIa trial presented at EAS 2025 suggest that targeting ANGPTL4 with a monoclonal antibody may significantly reduce triglycerides and remnant cholesterol in high-risk cardiovascular patients. MAR001 was well tolerated, with no serious adverse events. These results support further investigation in a larger Phase 2b study.

The EU-funded DORIAN GRAY project, aims to uncover how cardiovascular disease contributes to mild cognitive impairment using AI and avatar technology. By integrating real-world data from over 300,000 individuals, the initiative seeks to personalize prevention strategies, enhance cognitive health, and reduce dementia risk across Europe.

In this Q&A, we talk to Dr Nadia Chaher shares insights into her career so far, her experiences and the most exciting current innovations in cardio-imaging.